{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:15:21Z","timestamp":1787966121222,"version":"build-2784847793"},"reference-count":24,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2021,8,24]]},"abstract":"<jats:p>BACKGROUND: The Controlling Nutritional Status (CONUT) score, a novel immuno-nutritional index, was reported as a predictor of overall survival (OS) in some tumors. OBJECTIVE: We aimed to investigate the association between baseline CONUT Score and clinical outcomes in patients with multiple myeloma (MM). METHODS: We performed a retrospective analysis of 245 patients with MM. The CONUT score was determined prior to therapy. RESULTS: Among the entire cohort, the complete remission rate was markedly higher in the low-CONUT (\u2a7d 3) group compared to the mid-CONUT (4\u20139) group or high-CONUT (&gt; 9) group (44.1% vs 25.8%, P= 0.039; 44.1% vs 12.5%, P= 0.002). Patients with CONUT score &gt; 9 had significant poor prognosis, and CONUT score \u2a7d 3 group showed better survival outcome than other groups in OS (P&lt; 0.001). Besides, we stratified the patients by combining International Staging System (ISS) stage and CONUT score in a model, and found that CONUT score could improve the prognostic impact of ISS stages on OS. In multivariate analysis, older age (\u2a7e 70 years) and a high CONUT score (\u2a7e 4) were independent prognostic risk factors for OS. CONCLUSIONS: The CONUT score was a predictor of OS in MM patients especially in cases with both low ISS staging and CONUT score. The baseline CONUT score may be an early and practical indicator of the efficacy of anti-myeloma treatment.<\/jats:p>","DOI":"10.3233\/cbm-210073","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T12:35:08Z","timestamp":1622810108000},"page":"65-71","source":"Crossref","is-referenced-by-count":19,"title":["Association between baseline Controlling Nutritional Status score and clinical outcomes of patients with multiple myeloma"],"prefix":"10.1177","volume":"32","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"},{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"},{"name":"Department of Clinical Laboratory, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"},{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjue","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Wuxi People\u2019s Hospital, Nanjing Medical University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-210073_ref1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-210073_ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/joim.12590","article-title":"Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes","volume":"281","author":"Landgren","year":"2017","journal-title":"J Intern Med"},{"key":"10.3233\/CBM-210073_ref3","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-210073_ref4","doi-asserted-by":"crossref","unstructured":"S.V. Rajkumar, M.A. Dimopoulos, A. Palumbo et al., International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, Lancet Oncol 15 (2014), e538\u2013548.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"10.3233\/CBM-210073_ref5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/CBM-210073_ref6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group","volume":"69","author":"Dewys","year":"1980","journal-title":"Am J Med"},{"key":"10.3233\/CBM-210073_ref7","first-page":"38","article-title":"CONUT: a tool for controlling nutritional status, First validation in a hospital population","volume":"20","author":"Ignacio de Ulibarri","year":"2005","journal-title":"Nutr Hosp"},{"key":"10.3233\/CBM-210073_ref8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijsu.2020.04.046","article-title":"Prognostic significance of the controlling nutritional status (CONUT) score in patients with colorectal cancer: a systematic review and meta-analysis","volume":"78","author":"Takagi","year":"2020","journal-title":"Int J Surg"},{"key":"10.3233\/CBM-210073_ref9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1080\/01635581.2018.1490448","article-title":"Prognostic impact of nutritional status assessed by the controlling nutritional status (CONUT) score in patients with surgically treated renal cell carcinoma","volume":"70","author":"Kang","year":"2018","journal-title":"Nutr Cancer"},{"key":"10.3233\/CBM-210073_ref10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hon.2732","article-title":"Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma","volume":"38","author":"Nagata","year":"2020","journal-title":"Hematol Oncol"},{"key":"10.3233\/CBM-210073_ref11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00277-018-3502-7","article-title":"Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia\/lymphoma","volume":"98","author":"Ureshino","year":"2019","journal-title":"Ann Hematol"},{"key":"10.3233\/CBM-210073_ref12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12185-019-02723-w","article-title":"Prediction of clinical outcome by controlling nutritional status (CONUT) before allogeneic hematopoietic stem cell transplantation in myeloid malignancies","volume":"110","author":"Araie","year":"2019","journal-title":"Int J Hematol"},{"key":"10.3233\/CBM-210073_ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00277-019-03844-2","article-title":"Clinical impact of the CONUT score in patients with multiple myeloma","volume":"99","author":"Okamoto","year":"2020","journal-title":"Ann Hematol"},{"key":"10.3233\/CBM-210073_ref14","first-page":"1","article-title":"The prognostic value of the controlling nutritional status score in patients with multiple myeloma","volume":"19","author":"Kamiya","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.3233\/CBM-210073_ref15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.3233\/CBM-210073_ref16","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clinical Cancer Research"},{"key":"10.3233\/CBM-210073_ref17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1017\/S0029665118000459","article-title":"Nutrition support and clinical outcome in advanced cancer patients","volume":"77","author":"Laviano","year":"2018","journal-title":"Proc Nutr Soc"},{"key":"10.3233\/CBM-210073_ref18","doi-asserted-by":"crossref","first-page":"79884","DOI":"10.18632\/oncotarget.20168","article-title":"Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study","volume":"8","author":"Muscaritoli","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210073_ref19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/10428190902741471","article-title":"Diagnostic delay and complications for older adults with multiple myeloma","volume":"50","author":"Friese","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.3233\/CBM-210073_ref20","doi-asserted-by":"crossref","first-page":"e28207","DOI":"10.1002\/pbc.28207","article-title":"Review of nutritional status, body composition, and effects of antineoplastic drug disposition","volume":"21","author":"Wiernikowski","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.3233\/CBM-210073_ref21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.3233\/CBM-210073_ref22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/bjh.12465","article-title":"Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis","volume":"163","author":"Pozzi","year":"2013","journal-title":"Br J Haematol"},{"key":"10.3233\/CBM-210073_ref23","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: a report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-210073_ref24","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.12659\/MSM.907588","article-title":"Real-world clinical outcomes in elderly chinese patients with multiple myeloma: a single-center experience","volume":"24","author":"Qian","year":"2018","journal-title":"Med Sci Monit"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-210073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:15Z","timestamp":1777385295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-210073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":24,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/cbm-210073","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}